Experience of use of Konegra Deluxe in the therapy of erectile dysfunction
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The objective: the evaluation of the effectiveness of the medicine Konegra Deluxe in the form of pills in the treatment of erectile dysfunction.
Materials and methods. On the basis of the Department of Sexopathology and Andrology of the State Institution «Urology Institute of the National Academy of Medical Sciences of Ukraine», an open study of the medicine Konegra Deluxe was conducted. The study included 35 patients with erectile dysfunction of different genesis in the dynamics. After the termination of the course of treatment, 33 patients underwent a clinical and laboratory examination. Two patients did not complete the course of treatment for various reasons.
Results. In the group of patients receiving Konegra Deluxe, virtually all integration parameters that characterize the sexual sphere of the patient significantly increased. Changes in cavernous blood flow during the ultrasonic Doppler ultrasound method showed statistically and clinically significant changes during drug therapy. Patients and researchers assessed the effectiveness of the Konegra Deluxe preparation as follows: «excellent» – in 21 (63.6%) clinical case, «good» - in 9 (27.3%), «satisfactory» – in 2 (6.1% ) And «unsatisfactory» - in 1 (3.0%) case.
Conclusion. The clinical efficacy of Konegra Deluxe is 90.9%. Patients tolerated the treatment with Konegra Deluxe. The presence of side effects in 6.1% of patients was revealed, which does not affect the general condition of the patient. The medicine Konegra Deluxe can be considered the first choice drug in the treatment of erectile dysfunction in men.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Возіанов О.Ф., Горпинченко І.І. Досвід застосування віагри в Україні // Сексология и андрология. – К., 2000. – Вып. 5. – С. 3–5.
Горпинченко И.И. Эректильная дисфункция: диагностика и современные методы лечения // Здоровье мужчины. – 2002. – No 1. – С. 9–11.
Горпинченко И.И., Мирошников Я.О. Эректильная дисфункция. – Л.: «Медицина світу, 2003.
Горпинченко И.И. Геронтологическая сексопатология: Производственное издание Здоровья, 1991. – 168 с.
Rosen R.C., Riley A., Wagner G. et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction // Urology. – 1997. – V. 49. – P. 822–830.
Бюва Ж. Лечение силденафилом, четырёхлетний опыт // Здоровье мужчины. – 2002. – No 2. – С. 11–13.
Вагнер Г., Грин Р. Импотенция (физиология, психология, хирургия, диагностика и лечение). – М.: Медицина, 1985. – 240 с.
Goldstein І, Lue TF, PadmaNathan H, Rosen R, Steers WI, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction// New Engi J Med. – 1998; 338:1397–404.
Langtry HI, Markham A. Sildenafil. A review of its use in erectile dysfunction // Drugs 1999;57:845 039.
Sadovsky R, Miller T, Moskowitz M, Hackett G. Three year update of sildenafil citrate (Viagra) efficacy and safety // lot j Clin Pract 2001 ;55: 115–28.
Morales A, Gingell C, Collins M et al. Clinical safety of oral sildenafIl citrate in the treatment of erectile dysfunction // Jot J Impot Res 1998;10:69–73.
